Enrofloxacin Pharmacokinetics and Sampling Techniques in California Sea Hares (Aplysia californica)

Sharon E. Mason, Mark G. Papich, Michael C Schmale, Craig A. Harms, Sally A. Davis

Research output: Contribution to journalArticle

Abstract

This pharmacokinetic study was designed to determine the pharmacokinetics of enrofloxacin at 5 mg/kg when given to sea hares in their hemolymph. Enrofloxacin is a commonly used antimicrobial in veterinary medicine and potentially could be used to treat sea hares exposed to susceptible bacterial species. We individually identified 8 juvenile Aplysia californica and group housed them in an open seawater flow system at 14 to 18 °C; 2 served as untreated controls. The remaining 6 animals were injected into the hemocoel with 0.030 mL of 22.7 mg/mL enrofloxacin (average dose, 5 to 6 mg/kg). At each time point, 300 μL hemolymph was collected from the pedal hemolymph sinus and HPLC-analyzed for enrofloxacin and ciprofloxacin levels. Enrofloxacin was detected in all dosed animals, at an average peak concentration of 3 μg/mL in hemolymph, and remained in the body for 20.3 h with an average clearance of 0.19 μg × h/mL. No ciprofloxacin was detected in any Aplysia in this study. Hemocoel injection appears to be an effective way to administer enrofloxacin to Aplysia and reach clinically relevant concentrations. Enrofloxacin reached therapeutic target concentrations in A. californica when dosed according to the regimen described in the current report.

Original languageEnglish (US)
Pages (from-to)231-234
Number of pages4
JournalJournal of the American Association for Laboratory Animal Science : JAALAS
Volume58
Issue number2
DOIs
StatePublished - Mar 1 2019

Fingerprint

enrofloxacin
pharmacokinetics
hemolymph
hemocoel
sampling
ciprofloxacin
methodology
sinuses
Aplysia
Anaspidea
veterinary medicine
animals
seawater
anti-infective agents
injection
therapeutics
dosage

ASJC Scopus subject areas

  • Animal Science and Zoology

Cite this

Enrofloxacin Pharmacokinetics and Sampling Techniques in California Sea Hares (Aplysia californica). / Mason, Sharon E.; Papich, Mark G.; Schmale, Michael C; Harms, Craig A.; Davis, Sally A.

In: Journal of the American Association for Laboratory Animal Science : JAALAS, Vol. 58, No. 2, 01.03.2019, p. 231-234.

Research output: Contribution to journalArticle

@article{7968b276dde54f1ea972516ef84259c0,
title = "Enrofloxacin Pharmacokinetics and Sampling Techniques in California Sea Hares (Aplysia californica)",
abstract = "This pharmacokinetic study was designed to determine the pharmacokinetics of enrofloxacin at 5 mg/kg when given to sea hares in their hemolymph. Enrofloxacin is a commonly used antimicrobial in veterinary medicine and potentially could be used to treat sea hares exposed to susceptible bacterial species. We individually identified 8 juvenile Aplysia californica and group housed them in an open seawater flow system at 14 to 18 °C; 2 served as untreated controls. The remaining 6 animals were injected into the hemocoel with 0.030 mL of 22.7 mg/mL enrofloxacin (average dose, 5 to 6 mg/kg). At each time point, 300 μL hemolymph was collected from the pedal hemolymph sinus and HPLC-analyzed for enrofloxacin and ciprofloxacin levels. Enrofloxacin was detected in all dosed animals, at an average peak concentration of 3 μg/mL in hemolymph, and remained in the body for 20.3 h with an average clearance of 0.19 μg × h/mL. No ciprofloxacin was detected in any Aplysia in this study. Hemocoel injection appears to be an effective way to administer enrofloxacin to Aplysia and reach clinically relevant concentrations. Enrofloxacin reached therapeutic target concentrations in A. californica when dosed according to the regimen described in the current report.",
author = "Mason, {Sharon E.} and Papich, {Mark G.} and Schmale, {Michael C} and Harms, {Craig A.} and Davis, {Sally A.}",
year = "2019",
month = "3",
day = "1",
doi = "10.30802/AALAS-JAALAS-18-000072",
language = "English (US)",
volume = "58",
pages = "231--234",
journal = "Journal of the American Association for Laboratory Animal Science",
issn = "1559-6109",
publisher = "American Association for Laboratory Animal Science",
number = "2",

}

TY - JOUR

T1 - Enrofloxacin Pharmacokinetics and Sampling Techniques in California Sea Hares (Aplysia californica)

AU - Mason, Sharon E.

AU - Papich, Mark G.

AU - Schmale, Michael C

AU - Harms, Craig A.

AU - Davis, Sally A.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - This pharmacokinetic study was designed to determine the pharmacokinetics of enrofloxacin at 5 mg/kg when given to sea hares in their hemolymph. Enrofloxacin is a commonly used antimicrobial in veterinary medicine and potentially could be used to treat sea hares exposed to susceptible bacterial species. We individually identified 8 juvenile Aplysia californica and group housed them in an open seawater flow system at 14 to 18 °C; 2 served as untreated controls. The remaining 6 animals were injected into the hemocoel with 0.030 mL of 22.7 mg/mL enrofloxacin (average dose, 5 to 6 mg/kg). At each time point, 300 μL hemolymph was collected from the pedal hemolymph sinus and HPLC-analyzed for enrofloxacin and ciprofloxacin levels. Enrofloxacin was detected in all dosed animals, at an average peak concentration of 3 μg/mL in hemolymph, and remained in the body for 20.3 h with an average clearance of 0.19 μg × h/mL. No ciprofloxacin was detected in any Aplysia in this study. Hemocoel injection appears to be an effective way to administer enrofloxacin to Aplysia and reach clinically relevant concentrations. Enrofloxacin reached therapeutic target concentrations in A. californica when dosed according to the regimen described in the current report.

AB - This pharmacokinetic study was designed to determine the pharmacokinetics of enrofloxacin at 5 mg/kg when given to sea hares in their hemolymph. Enrofloxacin is a commonly used antimicrobial in veterinary medicine and potentially could be used to treat sea hares exposed to susceptible bacterial species. We individually identified 8 juvenile Aplysia californica and group housed them in an open seawater flow system at 14 to 18 °C; 2 served as untreated controls. The remaining 6 animals were injected into the hemocoel with 0.030 mL of 22.7 mg/mL enrofloxacin (average dose, 5 to 6 mg/kg). At each time point, 300 μL hemolymph was collected from the pedal hemolymph sinus and HPLC-analyzed for enrofloxacin and ciprofloxacin levels. Enrofloxacin was detected in all dosed animals, at an average peak concentration of 3 μg/mL in hemolymph, and remained in the body for 20.3 h with an average clearance of 0.19 μg × h/mL. No ciprofloxacin was detected in any Aplysia in this study. Hemocoel injection appears to be an effective way to administer enrofloxacin to Aplysia and reach clinically relevant concentrations. Enrofloxacin reached therapeutic target concentrations in A. californica when dosed according to the regimen described in the current report.

UR - http://www.scopus.com/inward/record.url?scp=85062992958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062992958&partnerID=8YFLogxK

U2 - 10.30802/AALAS-JAALAS-18-000072

DO - 10.30802/AALAS-JAALAS-18-000072

M3 - Article

C2 - 30819273

AN - SCOPUS:85062992958

VL - 58

SP - 231

EP - 234

JO - Journal of the American Association for Laboratory Animal Science

JF - Journal of the American Association for Laboratory Animal Science

SN - 1559-6109

IS - 2

ER -